Gluococorticoids are commonly prescribed to treat a number of diseases including the majority of inflammatory diseases. Despite considerable inter-personal variability in responses to glucocorticoids between asthmatics, an insensitivity rate of about 30% and the risk of adverse side effects of glucocorticoid therapy, no assay is currently performed to determine sensitivity in severe and non-severe asthmatics prior to treatment. The purpose of this study is to perform a whole blood ex vivo stimulation assay to interrogate known glucocorticoid receptor (GR) up- and down-regulated genes to indicate glucocorticoid sensitivity and compare the results between severe and non-severe asthmatics.
Study Type
OBSERVATIONAL
Enrollment
14
Martha Morehouse Medical Pavillion
Columbus, Ohio, United States
Martha Morehouse Medical Pavillion
Columbus, Ohio, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.